Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-07-02

Clinical Trial Update: Effect of Ropinirole on Spinal Cord Reflexes and Restless Legs Syndrome

View source ↗

Summary

NINDS-sponsored trial evaluating ropinirole for restless legs syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ropinirole (ropinirole)

Snippet

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) | Conditions: Restless Legs Syndrome | Status: COMPLETED